Small cap News

Moderna soared 177% Wednesday, while Merck gained 13% and the rally spread to BioNTech, Arcturus, Tempus AI and Novavax.

SpaceX could gain from fewer Starship bottlenecks and NASA’s Moon-Mars push.

ASTS already has FCC approval to test the same frequencies with up to 100 commercially available phones near Midland and Lanham through Sept.12.

China urged the U.S. to remove new tariffs on drones and related parts.

The breakthrough sparked a broad biotech rally, lifting Merck, BioNTech, Arcturus, cancer-treatment developers, gene-editing stocks and biotech ETFs.

Wood said soaring memory prices will encourage engineers to develop cheaper alternatives and attract additional supply.

Investors weigh Datavault AI’s tokenization backlog, AI infrastructure expansion, and revenue potential.

Morgan Stanley, UBS, Bank of America, Susquehanna and Millennium collectively added about 36 million Nio shares.

According to TheFly, Compass Point has a ‘Buy’ rating on Gorilla Technology shares with a $44 price target.

Analysts at Cantor Fitzgerald raised their price target on Duos to $27 from $26 while maintaining an ‘Overweight’ rating, implying an upside potential of about 118% from current levels.

A separate pediatric study delivered “striking” WT1 vaccine results, supporting GPS’s scientific rationale, the company's CEO said.

The sell-offs followed a failed trial, a massive recall, and a CEO's exit.

Duos Technologies said that the agreements cover an aggregate 55 MW of AI facility capacity across multiple U.S. data center sites

This comes as Serve Robotics looks to put more robots to work following its recent split with Uber Eats, with the company also launching a new micro-depot model and expanding beyond sidewalk delivery.

Critical Metals advances Tanbreez drilling, construction and pilot-plant work.

Goldman increased its stake in Sellas by 5.2% to 585,035 shares, worth $8.64 million.

Boost Run said that, as part of the deal, 10X has agreed to provide immediate access to 20 MW of GPU infrastructure capacity, with plans to scale to 111 MW across three sites through 2027.

Burry believes CoreWeave’s limited float, retail popularity, and short-squeeze potential make it too dangerous to bet against.

Vanguard held SLS and IBRX positions worth a combined $259 million at quarter-end.

Companies controlling launch and orbital infrastructure could capture “disproportionate value,” the research firm said.

Analyst Tim Farrar said Rocket Lab may be better shielded from SpaceX, while AST faces direct competition from Starlink.

Plunging antimony prices have eroded United States Antimony’s second-quarter revenue, prompting an outlook cut.

Weak results, a reverse split, analyst downgrades, and slowing growth concerns triggered sharp investor sell-offs.

Velo3D CEO Arun Jeldi highlighted capacity expansion, Livermore’s campus and growing aerospace demand.

RBC Capital kept a ‘Sector Perform’ rating on Upwork while citing pressure from both artificial intelligence trends and changes to Google's search algorithm.

Hertz plans to expand its franchise and rideshare businesses and support Uber’s robotaxi program using Lucid vehicles.

Weaker second-quarter sales and a Cyclospora-related health scare hit Sweetgreen demand and reduced guidance.

WTI crude crossed $78 as uncertainty over an Iran-Oman shipping agreement fueled inflation concerns.

Beyond Meat posted a second-quarter net profit of $16.4 million, compared with a net loss of $31.8 million last year.

Nio expects to deliver its 20,000th ES9 this week, about 10 weeks after customer handovers began.

The LivePerson acquisition could lift combined 2027 revenue to at least $350 million-$400 million.

SpaceX’s lockup expiration threatens to more than double its public float.

Shares of Digital Turbine hit a 52-week high on Wednesday after the company reported its first-quarter results earlier in the day.

Alisa Bowen, who succeeded co-founder David Gandler as CEO last month, said her confidence in FuboTV's differentiation and growth prospects has “only continued to build” since taking the role.

IBRX and SLS align with Big Pharma’s cancer push, fueling retail partnership and buyout speculation.

AT&T and Verizon anchor ASTS’ U.S. strategy, while its broader network includes nearly 60 carrier partners covering more than 3 billion subscribers.

Oppenheimer analyst Ittai Kidron raised his price target on Backblaze to $25 from $15 while maintaining an ‘Outperform’ rating, saying B2 cloud storage revenue came in well ahead of expectations.

Corvex said the agreement expands an existing customer commitment, with the full GPU cluster now fully deployed after deliveries throughout 2026.

Vontobel cut its holding by 16% but retained SLS shares worth $2.17 million.

Globalstar rose nearly 3% in July, outperforming a space sector in which several peers lost more than one-third of their value.

Investors became less willing to wait for companies’ long-term plans when those businesses continued to face problems delivering results in the short term.

A potential AstraZeneca-Bristol Myers deal worth $400 billion would create one of the world’s largest drugmakers and combine major cancer franchises.

Goldman Sachs says AI growth and energy demand are boosting critical minerals investments.

BlueBird satellites 11, 12 and 13 are scheduled to launch on Aug. 5 aboard a SpaceX Falcon 9.

The IDIQ runs through July 29, 2032 and lets selected firms compete for future test, evaluation and training task orders.

Investors responded by aggressively selling the stocks as concerns mounted over their near-term outlook.

Morningstar maintained a ‘No Moat’ view, citing low telehealth barriers and offerings rivals can replicate “with relative ease.”

Rocket Lab could gain from more NASA launch and space-systems work, while AST SpaceMobile may benefit from broader space-sector momentum.

Viking expects oral VK2735 Phase 3 studies to begin in Q4 and believes the pill could become the first oral dual GLP-1 agonist to reach the market.

New York State Common Retirement Fund boosted its holding by 70%, while Commonwealth and Axxcess each raised stakes by about 17%.